1. Home
  2. ENTA vs GCO Comparison

ENTA vs GCO Comparison

Compare ENTA & GCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$11.37

Market Cap

377.5M

Sector

Health Care

ML Signal

HOLD

Logo Genesco Inc.

GCO

Genesco Inc.

HOLD

Current Price

$36.46

Market Cap

421.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTA
GCO
Founded
1995
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Clothing/Shoe/Accessory Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
377.5M
421.8M
IPO Year
2012
1994

Fundamental Metrics

Financial Performance
Metric
ENTA
GCO
Price
$11.37
$36.46
Analyst Decision
Strong Buy
Hold
Analyst Count
6
4
Target Price
$21.83
★ $39.67
AVG Volume (30 Days)
★ 242.2K
96.0K
Earning Date
11-16-2026
12-03-2026
Dividend Yield
N/A
N/A
EPS Growth
29.93
★ 171.84
EPS
N/A
★ N/A
Revenue
$102,814,000.00
★ $2,606,898,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.38
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 16.48
13.71
52 Week Low
$10.20
$21.93
52 Week High
$17.15
$43.60

Technical Indicators

Market Signals
Indicator
ENTA
GCO
Relative Strength Index (RSI) 43.19 56.52
Support Level $10.86 $31.83
Resistance Level $13.95 $38.33
Average True Range (ATR) 0.64 1.28
MACD -0.08 0.15
Stochastic Oscillator 28.14 66.05

Price Performance

Historical Comparison
ENTA
GCO

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About GCO Genesco Inc.

Genesco Inc sells footwear, headwear, sports apparel, and accessories. It has four reportable business segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass. The brands of the company are: Journeys; Journeys Kidz; Little Burgundy; Schuh; Johnston & Murphy; and Genesco Brands Group.

Share on Social Networks: